Evidence map›Paper›PMID 34070485›Full record

ArticleInternational journal of environmental research and public health2021

Trends in Use of Prescription Skin Lightening Creams.

Dana S Saade, Mayra B C Maymone, Henriette De La Garza, Eric A Secemsky, Kevin F Kennedy, Neelam A Vashi

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Dana S SaadeDepartment of Dermatology, Boston University School of Medicine, Boston, MA 02118, USA.
Mayra B C MaymoneDepartment of Dermatology, Boston University School of Medicine, Boston, MA 02118, USA.
Henriette De La GarzaDepartment of Dermatology, Boston University School of Medicine, Boston, MA 02118, USA.ORCID 0000-0002-0005-1823
Eric A SecemskyDepartment of Medicine, Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
Kevin F KennedySaint-Luke's Mid America Heart Institute and University of Missouri-Kansas City School of Medicine, Kansas City, MO 64111, USA.
Neelam A VashiDepartment of Dermatology, Boston University School of Medicine, Boston, MA 02118, USA.

Funding

Shared Decision-Making to Improve the Health Status of Patients with Claudication: Developing and Implementing Strategies to Individualize Treatment DecisionsK23HL150290 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI SECEMSKY, ERIC ALEXANDER · 2020 to 2024
$851k
NHLBI NIH HHS K23 HL150290
6 · The paper itself

Abstract

The desire for an even skin tone pervades all cultures and regions of the world. Uniform skin color is considered a sign of beauty and youth. Pigmentation abnormalities can arise idiopathically with genetic predetermination, with injury and environmental exposures, and with advancing age, and can, therefore, be distressing to patients, leading them to seek a variety of treatments with professional assistance. In this short report, we describe the trends in the use of prescription lightening creams, particularly in patients with darker skin types residing in the US. Amongst 404 participants, skin hyperpigmentation had a moderate effect on patients' quality of life, and the most common diagnosis associated with the use of a prescription product was melasma (60.8%). The most common agent prescribed was hydroquinone (62.9%), followed by triple combination cream (31.4%). It is the dermatologist's duty to gauge the effect of the pigmentation disease on patients' life in order to counsel, tailor, and decide on the most appropriate treatment option.

Indexed as

HyperpigmentationMelanosisAdolescentHumansHydroquinonesPrescriptionsQuality of LifeSkin CreamTreatment OutcomeHydroquinoneshyperpigmentationlightening creammelasmaquality of lifeskin of color

Identifiers

PMID34070485
PMCPMC8197474

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.